Dual luciferase assays demonstrated that overexpression of KLF4 in Huh7 cells strongly enhanced WT-CD9/CD81 promoter activity, whereas knockdown of KLF4 resulted in opposite effects in HCC-LM3 cells. The gene discussed is KLF4; the disease is hepatocellular carcinoma.